FDA Approves Baqsimi: The First Low Blood Sugar Treatment WITHOUT an Injection
Type 1 diabetes (T1D) can bring the fear of developing low blood sugar, called hypoglycemia, which can arise if someone…
ADA Scientific Sessions Recap—Day #5: Marlon Pragnell, Ph.D.
The ADA’s Scientific Sessions is completed! Here, with the post-day recap, is Marlon Pragnell, Ph.D., head of the complications program…
End-stage kidney disease: A possible biomarker of 10-year risk—and therapeutic target—for people with T1D
In the United States, diabetic kidney disease, or DKD, is responsible for more than half of all new cases of…
